256 results on '"Trachtenberg, Barry H."'
Search Results
2. Contributors
3. Targeted treatments of AL and ATTR amyloidosis
4. TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study
5. Rare Variant Genetics and Dilated Cardiomyopathy Severity: The DCM Precision Medicine Study
6. Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy
7. A positive Tc-99m PYP scan in a patient with cardiac sarcoidosis
8. Association between digoxin use and gastrointestinal bleeding in contemporary continuous flow left ventricular assist device support
9. Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer
10. A principal components analysis of factors associated with successful implementation of an LVAD decision support tool
11. Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery
12. Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
13. Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial
14. Acquired and Hereditary Hypercoagulable States in Patients with Continuous Flow Left Ventricular Assist Devices: Prevalence and Thrombotic Complications
15. Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives
16. Persistent Blood Stream Infection in Patients Supported With a Continuous-Flow Left Ventricular Assist Device Is Associated With an Increased Risk of Cerebrovascular Accidents
17. A simplified echocardiographic technique for detecting continuous-flow left ventricular assist device malfunction due to pump thrombosis
18. 6 - Surgical risks
19. Roads, Maps, and Destinations: the Journey of Left Ventricular Assist Device Implantation in Ambulatory Patients with Advanced Heart Failure
20. Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice
21. Increased right-to-left ventricle diameter ratio is a strong predictor of right ventricular failure after left ventricular assist device
22. Risk Stratification of Patients With Current Generation Continuous-Flow Left Ventricular Assist Devices Being Bridged to Heart Transplantation
23. Melding a High-Risk Patient for Continuous Flow Left Ventricular Assist Device into a Low-Risk Patient
24. Inflammatory Cardiomyopathic Syndromes
25. Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European Ancestry.
26. Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulation
27. TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study
28. Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure
29. Validating an Idiopathic Dilated Cardiomyopathy Diagnosis Using Cardiovascular Magnetic Resonance: The Dilated Cardiomyopathy Precision Medicine Study
30. Effectiveness of the Family Heart Talk Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial.
31. Biomarkers of Oxidative Stress in Heart Failure
32. Targeted treatments of AL and ATTR amyloidosis
33. Presence of the V122I Variant of Hereditary Transthyretin-Mediated Amyloidosis Among Self-Reported White Individuals in a Sponsored Genetic Testing Program
34. Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer
35. Effectiveness of the Family Heart TalkCommunication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial
36. Additional file 1 of Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery
37. Additional file 2 of Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery
38. Defining Vasoplegia Following Durable, Continuous Flow Left Ventricular Assist Device Implantation
39. Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial
40. Baseline Global Longitudinal Strain Predictive of Anthracycline-Induced Cardiotoxicity
41. Delayed autologous stem cell transplantation following cardiac transplantation experience in patients with cardiac amyloidosis
42. Safety of serial MRI in patients with implantable cardioverter defibrillators
43. Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
44. A Principal Components Analysis of Factors Associated with Successful Implementation of an LVAD Decision Support Tool
45. Shared Decision Making In Cardiology Practice: 15 Month Results of A Multi-Site Study of Decision Aid Implementation
46. Baseline Global Longitudinal Strain Predictive of Anthracycline-Induced Cardiotoxicity
47. Should We Be for ASCT?
48. A positive Tc-99m PYP scan in a patient with cardiac sarcoidosis
49. Contributors
50. Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.